Menkes disease, or Menkes syndrome, is a rare hereditary disorder characterized by impaired copper metabolism in the body. This pathology is caused by mutations in the ATP7A gene, which codes for a protein responsible for copper transport. As a result of insufficient copper delivery to the body, especially to tissues, metabolism is disrupted, which leads to multiple clinical manifestations. Menkes disease manifests itself mainly in childhood, most often in boys, and is progressive. Symptoms may include delayed psychomotor development, muscle hypotonia, changes in hair structure, as well as vascular anomalies and nervous system disorders.
History of the disease and interesting historical facts
Menkes disease was first described in 1962 by physician and geneticist John Menkes, after which it was named after him. Despite its rarity, this syndrome has attracted scientific attention due to its unique mechanism of pathogenesis. Research in the field of genetics and copper metabolism has been developing since its discovery, and the disease continues to be the subject of active study to this day. In 1993, the ATP7A gene was identified, which was an important step towards understanding the molecular mechanism of the disease. In recent decades, new approaches to diagnosis and treatment have been developed, which has undoubtedly improved the quality of life of patients with this disease.
Epidemiology
According to the literature, the incidence of Menkes disease is approximately 1 case per 100,000 live births. The disease mainly affects boys; women are usually carriers of the gene, but do not clinically manifest the disease. In this regard, the pathology is significantly more common among the male population. Regions with a high frequency of detection of Menkes disease have not been identified, but this may be due to many factors, including the diversity of mutations and different detection rates among the population.
Genetic predisposition to this disease
Menkes disease is associated with mutations in the ATP7A gene, located on the X chromosome. This leads to a disruption in the synthesis of the protein responsible for copper transport in cells. There are different types of mutations that can lead to different forms of the disease. The most common mutations include:
- nucleotide substitutions;
- insertions and deletions;
- mutations in the regulatory elements of a gene.
Boys who inherit the mutation from their mother usually show clinical manifestations of the disease, while girls, being carriers, may not show symptoms. The probability of transmission of the disease from mother to son is 50%.
Risk factors for the development of this disease
The most significant risk factor for Menkes disease is gender, as the disease primarily affects men. Risk factors associated with the disease may also include:
- family history of the disease (presence of carriers in the family);
- potential environmental factors affecting drinking water and copper sources;
- exposure to toxic substances that disrupt copper metabolism.
Thus, risk factors are mainly related to genetic predisposition and transmission patterns of the disease.
Diagnosis of this disease
Diagnosis of Menkes disease involves a multi-step approach that begins with a clinical evaluation and history. Key symptoms to look for include:
- hypotension;
- delayed development;
- characteristic changes in hair (thin, curly, brittle);
- problems with sucking and swallowing;
- convulsive seizures.
Laboratory tests may include serum copper and circulating ceruloplasmin levels. Radiologic studies such as brain MRI may reveal changes in brain structures associated with the disease. Differential diagnosis includes conditions such as copper metabolism disorders, Wilson's disease, and other inherited mineral metabolism disorders.
Treatment
There is currently no definitive cure for Menkes disease, but some supportive therapies may be used. Common approaches include:
- copper therapy using copper chelate injections;
- supportive therapy to improve quality of life;
- psychomotor rehabilitation.
Pharmacological treatment may include drugs such as:
- paracetamol to reduce pain;
- anticonvulsants to control seizures;
- vitamins and minerals to support overall health.
In some cases, surgery may be required to correct anatomical abnormalities.
List of medications used to treat this disease
The list of drugs without which it is impossible to carry out therapy for Menkes disease includes:
- chelating agents (eg, D-cysteine);
- paracetamol;
- anticonvulsants;
- drugs to correct associated symptoms (eg, B vitamins).
The effectiveness of treatment depends on the patient’s age, the severity of the condition and the timeliness of diagnosis.
Disease monitoring
When monitoring Menkes disease, it is important to promptly identify and monitor for potential complications, which may include:
- neurological abnormalities;
- problems with the cardiovascular system;
- infectious diseases due to weakened immunity.
The prognosis for Menkes disease is generally poor, especially if left untreated. The patient may experience progressive deterioration of the condition throughout life, requiring ongoing attention from health care professionals.
Age-related features of the disease
Menkes disease usually presents in early childhood, but symptoms may vary depending on the patient's age. Neonates often present with severe hypotonia and abnormal hair. As children grow older, neurological problems may develop, leading to developmental delays and cognitive impairment. Patients may worsen their condition in later life (2 to 5 years), due to the progression of copper deficiency and its systemic manifestations.
Questions and Answers
- What causes Menkes disease?
The main cause of the disease is a mutation in the ATP7A gene, which disrupts copper metabolism in the body. - How is Menkes disease diagnosed?
Diagnosis includes a clinical examination, blood copper tests, and other tests such as an MRI of the brain. - What treatment is there for this disease?
There is currently no specific treatment, but supportive care and copper chelation are available. - At what age do symptoms of Menkes disease appear?
Symptoms usually appear early in life, often in the first months of life. - What is the prognosis for patients with Menkes disease?
The prognosis is generally poor, with progressive neurological and systemic impairment.
